glp-1 small molecule agonist PDB-101: of the Month: Receptor Agonists Oral Small-Molecule GLP-1 Receptor Agonists:

Food and Drug Administration (2025) Compounding when drugs are on FDAs drug shortages list, U.S

[DOI] [PMC free article] [PubMed] [Google Scholar] 47.Tomovic K., Lazarevic J., Kocic G., Deljanin-Ilic M., Anderluh M., Smelcerovic A

77 A meta-analysis of 76 RCTs, involving over 100,000 adults with overweight, obesity, or type 2 diabetes found that GLP-1 RA treatment, compared to placebo or other active comparators, was associated with a modestly elevated risk of cholelithiasis (RR: 1.27, 95% CI 1.10, 1.47), cholecystitis (RR: 1.36, 95% CI 1.14, 1.62), and overall biliary disease (RR: 1.55, 95% CI 1.08, 2.22), corresponding to an absolute increase of approximately 27 events per 10,000 patients per year

Also, GIP is a substance that enhances insulin sensitivity in adipocytes

List prices for GLP-1 drugs can top $1,000 for a months supply prior to insurance coverage, rebates, and discount coupons